The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 09, 2025

Filed:

Jun. 11, 2019
Applicant:

Symrise Ag, Holzminden, DE;

Inventors:

Stefan Brand, Vahlbruch, DE;

Matthias Winkler, Höxter, DE;

Marcus Rudolf Götz, Oberweser, DE;

Assignee:

SYMRISE AG, Holzminden, DE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 8/34 (2006.01); A61K 31/00 (2006.01); A61Q 19/02 (2006.01); C07C 37/48 (2006.01); C07C 37/72 (2006.01); C07C 37/74 (2006.01);
U.S. Cl.
CPC ...
A61K 8/347 (2013.01); A61K 31/658 (2023.05); A61Q 19/02 (2013.01); C07C 37/48 (2013.01); C07C 37/72 (2013.01); C07C 37/74 (2013.01); C07B 2200/13 (2013.01);
Abstract

The present invention relates to a method for producing cannabigerol and purifying it from a reaction mixture. The present invention also relates to the cosmetic use of cannabigerol for the inhibition of tyrosinase activity and/or the reduction of melanin production in the skin, in particular for reducing pigmentation of the skin, preferably for the improvement of the appearance of the skin in case of hyperpigmentation, lentigo or vitiligo. Furthermore, the present invention relates to cannabigerol for use in a therapeutic method for the inhibition of tyrosinase activity and/or the reduction of melanin production in the skin, preferably for use in a therapeutic method for the treatment and/or prevention of malign skin disorders, in particular skin cancer.


Find Patent Forward Citations

Loading…